Änderungen

Zur Navigation springen Zur Suche springen
253 Bytes hinzugefügt ,  18:37, 18. Mai 2008
K
Zeile 54: Zeile 54:     
weitere Studien:
 
weitere Studien:
 +
 +
*Shang, A et al., (2005) Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. In: The Lancet, 27. August–2. September 2005, Band 366 (9487), S. 726–732, PMID 16125589
 
* E. Ernst (2002), "A systematic review of systematic reviews of homeopathy", British Journal of Clinical Pharmacology 54 (6), 577–582: ..''Homeopathy remains one of the most controversial subjects in therapeutics. This article is an attempt to clarify its effectiveness based on recent systematic reviews. Electronic databases were searched for systematic reviews/meta-analysis on the subject. Seventeen articles fulfilled the inclusion/exclusion criteria. Six of them related to re-analyses of one landmark meta-analysis. Collectively they implied that the overall positive result of this meta-analysis is not supported by a critical analysis of the data. Eleven independent systematic reviews were located. Collectively they failed to provide strong evidence in favour of homeopathy. In particular, there was no condition which responds convincingly better to homeopathic treatment than to placebo or other control interventions. Similarly, there was no homeopathic remedy that was demonstrated to yield clinical effects that are convincingly different from placebo. It is concluded that the best clinical evidence for homeopathy available to date does not warrant positive recommendations for its use in clinical practice..''
 
* E. Ernst (2002), "A systematic review of systematic reviews of homeopathy", British Journal of Clinical Pharmacology 54 (6), 577–582: ..''Homeopathy remains one of the most controversial subjects in therapeutics. This article is an attempt to clarify its effectiveness based on recent systematic reviews. Electronic databases were searched for systematic reviews/meta-analysis on the subject. Seventeen articles fulfilled the inclusion/exclusion criteria. Six of them related to re-analyses of one landmark meta-analysis. Collectively they implied that the overall positive result of this meta-analysis is not supported by a critical analysis of the data. Eleven independent systematic reviews were located. Collectively they failed to provide strong evidence in favour of homeopathy. In particular, there was no condition which responds convincingly better to homeopathic treatment than to placebo or other control interventions. Similarly, there was no homeopathic remedy that was demonstrated to yield clinical effects that are convincingly different from placebo. It is concluded that the best clinical evidence for homeopathy available to date does not warrant positive recommendations for its use in clinical practice..''
 
* A. Paris, N. Gonnet, C. Chaussard, P. Belon, F. Rocourt, D. Saragaglia, J. L. Cracowski, "Effect of homeopathy on analgesic intake following knee ligament reconstruction: a phase III monocentre randomized placebo controlled study", British Journal of Clinical Pharmacology (OnlineEarly Articles). ''Conclusions: The complex of homeopathy tested in this study was not superior to placebo in reducing 24 h morphine consumption after knee ligament reconstruction...'' Der Witz bei dieser Studie ist, dass einer der Autoren (P. Belon) Direktor des französischen Homöopathie-Herstellers Boiron ist, die die Studie mitfinanziert haben.
 
* A. Paris, N. Gonnet, C. Chaussard, P. Belon, F. Rocourt, D. Saragaglia, J. L. Cracowski, "Effect of homeopathy on analgesic intake following knee ligament reconstruction: a phase III monocentre randomized placebo controlled study", British Journal of Clinical Pharmacology (OnlineEarly Articles). ''Conclusions: The complex of homeopathy tested in this study was not superior to placebo in reducing 24 h morphine consumption after knee ligament reconstruction...'' Der Witz bei dieser Studie ist, dass einer der Autoren (P. Belon) Direktor des französischen Homöopathie-Herstellers Boiron ist, die die Studie mitfinanziert haben.
23.054

Bearbeitungen

Navigationsmenü